Paediatric morphoea: a holistic review. Part 2: diagnosis, measures of disease activity, management and natural

A Kaushik1, R Mahajan1, D De1

  • 1Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Insights

Paediatric morphoea, a fibrosing skin disorder, presents challenges in management due to varied symptoms. This review details its diagnosis, activity markers, and treatment strategies for children.

Area of Science:

  • Dermatology
  • Rheumatology
  • Paediatric Medicine

Background:

  • Paediatric morphoea is a fibrosing condition affecting skin and subcutaneous tissues with unknown causes.
  • Optimal management strategies are difficult to define due to diverse presentations and limited pediatric studies.
  • This is the second part of a review, focusing on diagnosis, disease activity markers, management, and natural history.

Purpose of the Study:

  • To provide a comprehensive overview of the diagnosis, disease activity markers, management, and natural history of paediatric morphoea.
  • To synthesize current knowledge from relevant literature to aid clinicians in managing this condition.
  • To address the ongoing challenge of defining optimum management strategies for paediatric morphoea.

Main Methods:

  • A literature search was conducted on PubMed, MEDLINE, and Google Scholar.
  • Keywords included 'pediatric morphea', 'juvenile localised scleroderma', and 'juvenile systemic sclerosis'.
  • Relevant studies such as randomized trials, reviews, and original research articles were selected and analyzed.

Main Results:

  • The review synthesizes information on diagnostic approaches for paediatric morphoea.
  • Key markers for assessing disease activity are discussed.
  • Current management strategies and the natural course of the condition in children are summarized.

Conclusions:

  • Effective diagnosis and monitoring are crucial for managing paediatric morphoea.
  • Evidence-based management strategies are essential for improving patient outcomes.
  • Further research focusing on paediatric-specific studies is needed to optimize treatment protocols.